U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06952855) titled 'Observationa Study is a Prospective and Multi-institutional Observational Study.' on March 11.
Brief Summary: This observational study is a prospective, multi-institutional non intervention study to examine the prescription patterns, corresponding treatment effects and safety in routine clinical practice for patients prescribed for the treatment of gastroesophageal reflux disease.
Study Start Date: Nov. 01, 2024
Study Type: OBSERVATIONAL
Condition:
Erosive Reflux Disease
Heartburn
Acid Regurgitation
Recruitment Status: RECRUITING
Sponsor: Jeil Pharmaceutical Co., Ltd.
Published by HT Digital Content Services with permission fro...